Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment

Figure 5

Kaplan–Meier curves reveal the progression-free survival (PFS) differences based on mRNA level of CXC chemokines in OC patients. High expression of CXCL1, CXCL3, and CXCL10 and low expression of CXCL11, CXCL12, CXCL14, CXCL16, and CXCL17 are remarkably correlated with long PFS.